NCT04619121 Near-infrared Radiation-transcranial Photobiomodulation for Major Depressive Disorder Status COMPLETED Phase NA
NCT04618263 Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers Status TERMINATED Phase PHASE1
NCT04615234 Clinical Validation of a Combinatorial Pharmacogenomic Approach in Major Depressive Disorder Status UNKNOWN Phase N/A
NCT04607226 Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1) Status COMPLETED Phase NA
NCT04602715 The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression Status UNKNOWN Phase PHASE2
NCT04598607 Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04594616 Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD) Status WITHDRAWN Phase NA
NCT04593563 The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder Status UNKNOWN Phase PHASE2
NCT04591301 The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04589143 A Double-blind, Placebo-controlled Study of Antidepressant Augmentation With Agomelatine Status COMPLETED Phase PHASE4
NCT04576182 Supportive-Expressive and Emotion-Focused Treatment for Depression Status RECRUITING Phase NA
NCT04543773 Individualized Targeting and Neuromodulation of Late-Life Depression Status ACTIVE_NOT_RECRUITING Phase NA